HEB stock forecast
Our latest prediction for Hemispherx Biopharma Inc - HEB's stock price was made on the June 27, 2019 when the stock price was at 4.39$.
In the short term (2weeks), HEB's stock price should outperform the market by 5.70%. During that period the price should oscillate between -12.83% and +24.99%.
In the medium term (3months), HEB's stock price should underperform the market by -0.60%. During that period the price should oscillate between -27.30% and +54.25%.
Get email alertsCreate a solid portfolio with HEB
About Hemispherx Biopharma Inc - HEB
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -9.68$ per share.
The book value per share is 0.19$
Three months stock forecastJune 27, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -191.60% | -12M | - | -10M | -9.68 | - | - | 1M | 0.19 | -10M | - | -10M |